Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyAmyloidosisTeam Member asked a question 💭
Detroit, MI
October 5, 2024
 · 
Reactions
A MyAmyloidosisTeam Member

Pfizer developed Tafadamis by studying and mimicking Diflusinal

October 5, 2024
A MyAmyloidosisTeam Member

I'm doing okay, thanks Joe. I hope you're doing well.

October 5, 2024
A MyAmyloidosisTeam Member

How are you Sheldon?---Joe

October 5, 2024
MyAmyloidosisTeam

Tafamidis and diflunisal are both used to treat wild-type amyloidosis, but they work differently:

- Tafamidis: FDA-approved to treat heart disease in wild-type amyloidosis. It stabilizes the TTR protein, preventing amyloid fibril formation
- Diflunisal: Used off-label for amyloidosis. It works similarly to tafamidis by Show Full Answer

Tafamidis and diflunisal are both used to treat wild-type amyloidosis, but they work differently:

- Tafamidis: FDA-approved to treat heart disease in wild-type amyloidosis. It stabilizes the TTR protein, preventing amyloid fibril formation.
- Diflunisal: Used off-label for amyloidosis. It works similarly to tafamidis by stabilizing TTR proteins, but it is not officially approved for this use.

Both can help improve survival rates and quality of life for people with wild-type amyloidosis.

October 5, 2024

Related Questions

View All
A MyAmyloidosisTeam Member asked a question 💭
Paris, AR